CompanyCore
UK company intelligence
Company profile report
Prepared 03 June 2026
ACACIA PHARMA LIMITED
05934843 · ltd · incorporated 2006-09-14
1. Company facts
- Status
- active
- Lifecycle
- 🌳 Mature — Long-running with flat or slow growth. Steady cash, limited upside.
- Jurisdiction
- england-wales
- Registered office
- 3rd Floor 1 Ashley Road, Altrincham, WA14 2DT, United Kingdom
- SIC codes
- 72110 — Research and experimental development on biotechnology
- Accounts next due
- 2026-09-30
- Confirmation statement next due
- 2026-10-12
2. Directors (2 active)
- HUSSAIN, Debra Marie
- director · appointed 2024-05-22 · born 12/1968 (age 58)
- O’CONNOR, Daniel
- director · appointed 2025-02-04 · born 10/1980 (age 46)
3. Shareholders (1 active)
- Acacia Pharma Group Limited
- 75-100% shares · 75-100% voting · board control
4. Group structure
Acacia Pharma Group Limited is the ultimate parent — holding 75%+ shares. This company sits inside their group.
- Acacia Pharma Group Limited
- Corporate parent · 75-100%
5. Security
6 total charges (0 outstanding, 6 satisfied).
Headline verdict
- Opportunity score
- 78/100 (Strong)
- Owner dependency
- high — 66/100
- Red flags
- 0 high · 1 medium · 0 low